Revisions for 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

Revision Operations
12/29/2022 - 01:43 by Alicanto Admin

Current revision